US Stock MarketDetailed Quotes

ABVX Abivax S.A.

Watchlist
  • 7.650
  • -0.110-1.42%
Close Dec 20 16:00 ET
  • 7.650
  • 0.0000.00%
Post 16:12 ET
481.35MMarket Cap-2.15P/E (TTM)
Full Hours
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

Comments

    $Abivax S.A. (ABVX.US)$
    Abivax Provides Update on Ulcerative Colitis (UC) Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease (IBD) Mouse Model
    Abivax has announced initial preclinical combination data of obefazimod and etrasimod in an inflammatory bowel disease (IBD) mouse model. The company is conducting studies with multiple oral and injectable therapies, with additional data expected in Q4 2024. The p...
Read more
Heat List
US
Overall
Symbol
Price
% Chg

No Data